|
Lawmaker Calls for Investigation Into Drug, Device Discrepancies
Sen. Al Franken (D-Minn.) is asking the Government Accountability Office (GAO) to investigate why devicemakers don’t receive the same incentives as drugmakers to create products for rare diseases. The request is in a letter sent July 21, the same day the Senate Health, Education, Labor and Pensions Committee held a hearing on treating rare and neglected pediatric diseases. “I’m concerned that we still don’t have equivalent incentives for devices as we have for drugs,” Franken said at the hearing. “I think we can do more.”
Devices & Diagnostics Letter |
|
Register Now
Archives